Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triapine and Gemcitabine in Pancreatic Cancer
NCT00064051Phase 2Completed
- Sponsor
- Vion Pharmaceuticals
- Start
- Jan 2003
- Primary completion
- Aug 2006
- Countries
- 3
01
Overview
Phase 2, open-label trial of triapine in pancreatic cancer (PC) (2 cohorts), sponsored by Vion Pharmaceuticals. Primary endpoint: Objective Response Rate. Started Jan 2003; status: completed.
02
Drugs
triapine
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00064051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00064051.